Wachtell Lipton Discusses Mergers and Acquisitions–2022 and 2023
Reynolds Holding
FEBRUARY 1, 2023
At the same time, indications that regulators are focusing on the effects of healthcare deals, including a June 2022 workshop hosted by the FTC and the DOJ to explore new approaches to regulating pharmaceutical M&A, will put a premium on thoughtful transaction planning in this space. billion acquisition of One Medical).
45 
Let's personalize your content